Prevalence and predictors of bias in the reporting of primary efficacy and toxicity endpoints in randomized clinical trials of radiation oncology.
about
Prevalence and predictors of bias in the reporting of primary efficacy and toxicity endpoints in randomized clinical trials of radiation oncology.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Prevalence and predictors of b ...... trials of radiation oncology.
@en
Prevalence and predictors of b ...... trials of radiation oncology.
@nl
type
label
Prevalence and predictors of b ...... trials of radiation oncology.
@en
Prevalence and predictors of b ...... trials of radiation oncology.
@nl
prefLabel
Prevalence and predictors of b ...... trials of radiation oncology.
@en
Prevalence and predictors of b ...... trials of radiation oncology.
@nl
P2093
P2860
P356
P1476
Prevalence and predictors of b ...... l trials of radiation oncology
@en
P2093
Desiree Chen
Teng Hwee Tan
Yu Yang Soon
P2860
P304
P356
10.1111/1754-9485.12494
P50
P577
2016-07-11T00:00:00Z